Multiple administrations of oligodeoxynucleotides containing CpG motifs influence Ig isotype production

S Sethi1, S Ebner, C Hinske

  • 1Center for Neuropathology and Prion Research, Ludwig-Maximilians Universität München, München, Germany.

Insights

Multiple administrations of CpG-ODN boost IgG2c antibody levels, indicating a Th1 immune bias. This repeated immune activation may enhance anti-infection and anti-tumor effects but carries risks of autoimmunity.

Area of Science:

  • Immunology
  • Innate Immunity
  • Humoral Immunity

Background:

  • CpG-ODN activate innate immune cells, offering short-term resistance against infections and tumors.
  • Prolonging CpG-ODN effects requires multiple administrations, but carries risks of immune overactivation, like septic shock and autoimmunity.

Purpose of the Study:

  • To investigate the effects of multiple CpG-ODN administrations on immune responses.
  • To analyze Th1- and Th-2-associated immunoglobulin (Ig) antibody levels following repeated CpG-ODN treatment.

Main Methods:

  • Mice were administered CpG-ODN multiple times.
  • Levels of Th1- and Th-2-associated Ig antibodies were measured during and after treatment.

Main Results:

  • Multiple CpG-ODN administrations significantly increased total IgG2c levels in treated mice compared to controls.
  • This increase in IgG2c showed a distinct time and frequency correlation, even without additional stimuli.
  • Results indicate a humoral Th1 bias due to stimulation of Th1-Ig isotype-producing B cells.

Conclusions:

  • Repeated CpG-ODN administration induces a Th1-biased humoral immune response, evidenced by elevated IgG2c levels.
  • This Th1 bias may explain the observed anti-infection and anti-tumor properties of multiple CpG-ODN treatments.
  • Potential risks include the induction of autoimmune diseases due to inappropriate immune activation.

Related Concept Videos